These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16463802)

  • 1. [Gout].
    Carey Berner I; Dudler J
    Rev Med Suisse; 2006 Jan; 2(48):160-2. PubMed ID: 16463802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on gout and hyperuricemia.
    Baker JF; Schumacher HR
    Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT; Pillinger MH
    Bull NYU Hosp Jt Dis; 2009; 67(3):285-90. PubMed ID: 19852752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febuxostat: a new treatment for hyperuricaemia in gout.
    Edwards NL
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii15-ii19. PubMed ID: 19447778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricaemia and gout: state of the art and future perspectives.
    Dalbeth N; So A
    Ann Rheum Dis; 2010 Oct; 69(10):1738-43. PubMed ID: 20858623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapies in the long-term management of hyperuricaemia and gout.
    Stamp LK; O'Donnell JL; Chapman PT
    Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat for prevention of gout attacks.
    Pohar S; Murphy G
    Issues Emerg Health Technol; 2006 Aug; (87):1-4. PubMed ID: 16958189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.
    Bruce SP
    Ann Pharmacother; 2006 Dec; 40(12):2187-94. PubMed ID: 17132810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperuricemia. When and how to treat?].
    Reuss-Borst MA
    Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding treatments for gout.
    Cannella AC; Mikuls TR
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
    Sherman MR; Saifer MG; Perez-Ruiz F
    Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of gout in patients with chronic kidney disease].
    Bertrand J; Genevay S; Saudan P
    Rev Med Suisse; 2011 Mar; 7(284):483-6, 488-9. PubMed ID: 21462517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia, gout and the metabolic syndrome.
    Puig JG; Martínez MA
    Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future therapeutic options for the management of gout.
    Whelton A
    Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the management of gout and hyperuricaemia.
    Hoskison TK; Wortmann RL
    Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical implications of hyperuricemia.
    Sachs L; Batra KL; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.